The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Contemporary outcomes for adults with AML requiring ICU admission.
 
Danielle Hammond
No Relationships to Disclose
 
Koji Sasaki
Honoraria - Otsuka
Consulting or Advisory Role - Novartis; Pfizer; Takeda
Research Funding - Novartis
Travel, Accommodations, Expenses - Otsuka
 
Alexis Geppner
No Relationships to Disclose
 
Fadi Haddad
No Relationships to Disclose
 
Shehab Mohamed
No Relationships to Disclose
 
Daniel Rivera
No Relationships to Disclose
 
Maria Siddiqui
No Relationships to Disclose
 
Yasmin Alwash
No Relationships to Disclose
 
Jorge Ramos Perez
No Relationships to Disclose
 
Kiyomi Morita
No Relationships to Disclose
 
Kunhwa Kim
No Relationships to Disclose
 
Sherry Pierce
No Relationships to Disclose
 
Cristina Gutierrez
Honoraria - Janssen; Legend Biotech
Consulting or Advisory Role - Janssen; Legend Biotech
 
Naveen Pemmaraju
Employment - MD Anderson Cancer Center
Leadership - ASCO; ASH
Honoraria - Abbvie; Blueprint Medicines; Celgene; DAVA Pharmaceuticals; Incyte; LFB Biotechnologies; MustangBio; Novartis; Roche Molecular Diagnostics; Springer; Stemline Therapeutics
Consulting or Advisory Role - Blueprint Medicines; Bristol Myers Squibb; Immunogen; Pacylex
Research Funding - Abbvie; Affymetrix/Thermo Fisher Scientific; Cellectis; Daiichi Sankyo; Novartis; Plexxikon; Samus Therapeutics; Stemline Therapeutics
Travel, Accommodations, Expenses - Abbvie; Celgene; DAVA Oncology; MustangBio; Stemline Therapeutics
(OPTIONAL) Uncompensated Relationships - Dan's House of Hope; Oncology Times
 
Gautam Borthakur
Consulting or Advisory Role - Argenx; BiolineRx; BioTheryX; Catamaran Bio; Nkarta; Novartis; PTC Therapeutics; Takeda; Treadwell Therapeutics
Research Funding - Abbvie (Inst); Arvinas (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); BiolineRx (Inst); BioTheryX (Inst); Bristol-Myers Squibb (Inst); Cellestia Biotech (Inst); Cyclacel (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen Scientific Affairs (Inst); Lilly (Inst); MedImmune (Inst); Mundipharma Research (Inst); Nkarta (Inst); Nkarta (Inst); Novartis (Inst); Oncoceutics (Inst); PTC Therapeutics (Inst); Ryvu Therapeutics (Inst); TCR2 Therapeutics (Inst); Treadwell Therapeutics (Inst); XBiotech (Inst)
 
Courtney Denton Dinardo
Leadership - Notable Labs
Stock and Other Ownership Interests - Notable Labs
Honoraria - Abbvie; Agios; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Takeda
Consulting or Advisory Role - Abbvie; Agios; Celgene
Research Funding - Abbvie; AGIOS; Celgene; Daiichi Sankyo
 
Farhad Ravandi
Honoraria - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; AstraZeneca; Bristol Myers Squibb; Celgene; Jazz Pharmaceuticals; Novartis; Orsenix; Pfizer; Takeda
Consulting or Advisory Role - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; AstraZeneca; Bristol Myers Squibb; Celgene; Certara Inc; Jazz Pharmaceuticals; Orsenix; Syros Pharmaceuticals; Taiho Oncology; Taiho Oncology
Research Funding - Amgen; Bristol-Myers Squibb; Cellerant; Macrogenics; Selvita; Xencor
 
Guillermo Garcia-Manero
Honoraria - Abbvie; Acceleron Pharma; Astex Pharmaceuticals; Celgene; Helsinn Healthcare
Consulting or Advisory Role - Acceleron Pharma; Astex Pharmaceuticals; Bristol-Myers Squibb; Celgene; Helsinn Therapeutics; Jazz Pharmaceuticals
Research Funding - Abbvie; Amphivena; Astex Pharmaceuticals; Bristol-Myers Squibb; celgene; H3 Biomedicine; Helsinn Therapeutics; Merck; Novartis; Onconova Therapeutics
 
Hagop M. Kantarjian
Honoraria - Abbvie; Actinium Pharmaceuticals; Agios; Amgen; ARIAD; Bristol-Myers Squibb; Immunogen; Orsenix; Pfizer; Takeda
Research Funding - Abbvie (Inst); Agios (Inst); Agios (Inst); Agios (Inst); Amgen (Inst); ARIAD (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Cyclacel (Inst); Immunogen (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst)
 
Tapan M. Kadia
Consulting or Advisory Role - Abbvie/Genentech; Agios; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Amgen; Ascentage Pharma; Astellas Pharma; AstraZeneca; BiolineRx; Bristol-Myers Squibb; Celgene; Cyclacel; Genentech/Abbvie; Genfleet Therapeutics; Incyte; Jazz Pharmaceuticals; Pfizer; Sanofi